EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sublingual immunization with E2-CD154 protein and the STING agonist c-di-AMP confers protection against classical swine fever virus in pigs

Sara Puente-Marin, Talía Sardina-González, Liani Coronado, Cristina Riquelme, Saray Heredia, Adriana Muñoz-Aguilera, Yusmel Sordo-Puga, Danny Pérez-Pérez, Alina Rodríguez-Mallon, Mario Pablo Estrada, Carlos A Duarte, María Pilar Rodríguez-Moltó und 1 weitere

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1713724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Sara Puente-Marin und 12 weiteren Autor:innen. Beteiligte Einrichtung: IRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain. Hauptthemen laut MEDLINE: Classical Swine Fever, Classical Swine Fever Virus, Viral Vaccines, Viral Envelope Proteins. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Subunit vaccines represent a safer alternative to live attenuated formulations. However, they often require potent adjuvants and delivery systems to elicit robust immunity, particularly against highly contagious diseases such as Classical Swine Fever (CSF).

Methods

In this study, we investigated the immunogenicity and protective efficacy of a novel mucosal subunit vaccine comprising the chimeric E2-CD154 protein, co-administered with the mucosal adjuvant c-di-AMP, in domestic pigs. Optimal dosing and immunization schedules for sublingual immunization were determined, followed by a challenge experiment using a highly virulent CSF virus (CSFV) strain.

Results

Our results showed that sublingual co-administration of E2-CD154 and the STING agonist c-di-AMP conferred robust clinical protection, effectively prevented viral replication, and restricted the dissemination of infectious virus. This combination induced strong systemic IgG and IgA responses and neutralizing antibodies against multiple CSFV strains, achieving outcomes comparable with the commercial Porvac ® vaccine, administered intramuscularly. Importantly, virus isolation from tonsils confirmed the absence of infectious virus in pigs immunized with E2-CD154 and c-di-AMP, unlike those receiving E2-CD154 or the adjuvant alone. Moreover, immunized animals exhibited minimal IFN-α serum levels post-challenge, indicating reduced innate activation and viral replication.

Discussion

These findings provide evidence, in a large mammalian host such as the pig, that c-di-AMP functions as an adjuvant for a recombinant E2-CD154 protein delivered sublingually, enhancing immune responses consistent with protection against viral replication. Together, these results offer insights into the development of non-replicating, DIVA-compatible platforms against CSFV and support the rational design of next-generation subunit vaccines targeting viral pathogens relevant to both veterinary and human medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Classical Swine FeverClassical Swine Fever VirusViral VaccinesViral Envelope ProteinsCD40 LigandDinucleoside PhosphatesAnimalsSwineAntibodies, ViralAdministration, SublingualAntibodies, NeutralizingVaccines, SubunitAdjuvants, ImmunologicImmunoglobulin GImmunoglobulin AImmunizationVirus ReplicationVaccination

Stichwörter der Autor:innen

DIVA strategyE2-CD154 chimeric proteinc-di-AMPclassical swine fever virus (CSFV)porcine immunizationrecombinant subunit vaccinesublingual vaccination

Substanzen

Antibodies, ViralViral VaccinesViral Envelope ProteinsAntibodies, NeutralizingVaccines, SubunitCD40 LigandAdjuvants, ImmunologicDinucleoside PhosphatesImmunoglobulin Gglycoprotein E2, classical swine fever virus

Autor:innen und Institutionen

  • IRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain.
  • Unitat mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain.
  • WOAH Reference Laboratory for Classical Swine Fever, Institute of Agrifood Research and Technology, Centre de Recerça en Sanitat Animal (CReSA), Barcelona, Spain.
  • Departamento de Salud Animal, Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba.
  • Subgerencia de Análisis y Diagnóstico, Instituto Colombiano Agropecuario (ICA), Bogotá, Colombia.

Zitieren

APA

Puente-Marin, S., Sardina-González, T., Coronado, L., Riquelme, C., Heredia, S., Muñoz-Aguilera, A., Sordo-Puga, Y., Pérez-Pérez, D., Rodríguez-Mallon, A., Estrada, M. P., Duarte, C. A., Rodríguez-Moltó, M. P., & Ganges, L. (2025). Sublingual immunization with E2-CD154 protein and the STING agonist c-di-AMP confers protection against classical swine fever virus in pigs. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1713724

Vancouver

Puente-Marin S, Sardina-González T, Coronado L, Riquelme C, Heredia S, Muñoz-Aguilera A, et al. Sublingual immunization with E2-CD154 protein and the STING agonist c-di-AMP confers protection against classical swine fever virus in pigs. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1713724

BibTeX
@article{PuenteMarin2025,
  author = {Puente-Marin, Sara and Sardina-González, Talía and Coronado, Liani and Riquelme, Cristina and Heredia, Saray and Muñoz-Aguilera, Adriana and Sordo-Puga, Yusmel and Pérez-Pérez, Danny and Rodríguez-Mallon, Alina and Estrada, Mario Pablo and Duarte, Carlos A and Rodríguez-Moltó, María Pilar and Ganges, Llilianne},
  title = {Sublingual immunization with E2-CD154 protein and the STING agonist c-di-AMP confers protection against classical swine fever virus in pigs},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1713724}
}
Kostenlos starten →